echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority for the treatment of interstitiotic pulmonary disease (uILD) that cannot be classified!

    New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority for the treatment of interstitiotic pulmonary disease (uILD) that cannot be classified!

    • Last Update: 2021-03-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.